Table 1 Changes (mean ± SD) between the pre- and post-training time points in the ascending (ASW; n = 15) and descending stair walking (DSW; n = 15) groups for body mass, body mass index (BMI), percent body fat, resting heart rate (HR), systolic (SBP) and diastolic blood pressure (DBP), maximal voluntary isometric contraction strength of the knee extensors (MVIC), performance in the 30-s chair stand (CS), 2-min step (2MS), 6-m walk (6 MW), 6-m tendon walk (TW) test, balance with eyes open on firm surface (EOFS), balance with eyes closed on unstable surface (ECUS), upper thigh circumference (CIR), and bone mineral density (BMD).

From: Changes in plasma C1q, apelin and adropin concentrations in older adults after descending and ascending stair walking intervention

 

Group

Pre

Post

 

Group

Pre

Post

 

Group

Pre

Post

Body mass (kg)

ASW

62.7 ± 6.4

62.1 ± 5.9#

BMI (kg/m2)

ASW

26.1 ± 0.8

25.8 ± 0.7#

Body fat (%)

ASW

34.6 ± 5.3

33.4 ± 4.8#

DSW

62.8 ± 5.1

61.7 ± 5.2#

DSW

26.2 ± 1.1

25.7 ± 1.1#

DSW

36.4 ± 3.3

35.1 ± 3.4#

HR (beats/min)

ASW

80.3 ± 4.7

77.1 ± 5.1#

SBP (mmHg)

ASW

122.6 ± 11.7

118.5 ± 12.4#

DBP (mmHg)

ASW

69.3 ± 7.7

65.6 ± 7.5#

DSW

79.2 ± 4.5

71.5 ± 6.2#,*

DSW

119.9 ± 9.3

109.7 ± 10.8#,*

DSW

69.1 ± 7.2

64.1 ± 7.1#

MVIC (N)

ASW

245.3 ± 29.4

280.5 ± 27.3#

CS (times)

ASW

16.5 ± 1.4

19.9 ± 1.6#

2MS (times)

ASW

111.0 ± 5.1

118.9 ± 6.0#

DSW

262.4 ± 25.5

352.2 ± 55.7#,*

DSW

15.0 ± 1.3

21.3 ± 3.5#,*

DSW

110.1 ± 4.7

122.2 ± 14.5#

6 MW (m)

ASW

467.0 ± 38.9

482.6 ± 34.2#

TW (s)

ASW

27.1 ± 4.2

24.0 ± 2.7#

EOFS (SI)

ASW

0.69 ± 0.06

0.64 ± 0.07#

DSW

460.1 ± 31.3

496.1 ± 41.6#

DSW

26.3 ± 4.0

21.6 ± 4.7#

DSW

0.68 ± 0.05

0.52 ± 0.09#,*

ECUS (SI)

ASW

2.86 ± 0.20

2.72 ± 0.31#

CIR (cm)

ASW

48.1 ± 3.7

48.4 ± 3.6#

BMD (m/s)

ASW

1492.3 ± 66.3

1496.8 ± 36.1

DSW

2.88 ± 0.25

2.08 ± 0.43#,*

DSW

48.6 ± 2.6

49.2 ± 2.5#

DSW

1487.5 ± 55.3

1576.9 ± 69.7#,*

  1. #: significant (p ≤ 0.05) difference compared with the pre-training level. *: significant (p ≤ 0.05) difference compared with the ASW group.